Journal of Materials Science: Materials in Medicine

, Volume 12, Issue 10, pp 865-870

First online:

Phosphorylcholine-based polymer coatings for stent drug delivery

  • A. L. LewisAffiliated withBiocompatibles Ltd. Email author 
  • , T. A. VickAffiliated withBiocompatibles Ltd.
  • , A. C. M. ColliasAffiliated withBiocompatibles Ltd.
  • , L. G. HughesAffiliated withBiocompatibles Ltd.
  • , R. R. PalmerAffiliated withBiocompatibles Ltd.
  • , S. W. LeppardAffiliated withBiocompatibles Ltd.
  • , J. D. FurzeAffiliated withBiocompatibles Ltd.
  • , A. S. TaylorAffiliated withBiocompatibles Ltd.
  • , P. W. StratfordAffiliated withBiocompatibles Ltd.

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Phosphorylcholine-based polymers have been used commercially to improve the biocompatibility of coronary stents. In this study, one particular polymer is assessed for its suitability as a drug delivery vehicle. Membranes of the material are characterized in terms of water content and molecular weight cut-off, and the presence of hydrophilic and hydrophobic domains investigated by use of the hydrophobic probe pyrene. The in vitro loading and elution of a variety of drugs was assessed using stents coated with the polymer. The rate of a drug's release was shown not to be simply a function of its water solubility, but rather more closely related to the drug oil/water partition coefficient. This finding was explained in terms of the more hydrophobic drugs partitioning into, and interacting with, the hydrophobic domains of the polymer coating. The suitability of the coated stent as a drug delivery vehicle was assessed in vivo using a radiolabeled analog of one of the more rapidly eluting drugs, angiopeptin. Autoradiography showed that the drug was released locally to the wall of the stented artery, and could be detected up to 28 days after implantation.

© 2001 Kluwer Academic Publishers